Ignite Creation Date:
2024-05-05 @ 4:34 PM
Last Modification Date:
2024-10-26 @ 9:21 AM
Study NCT ID:
NCT00264043
Status:
COMPLETED
Last Update Posted:
2008-08-06
First Post:
2005-12-09
Brief Title:
The Study to Evaluate Patient Outcome Using Distal Protection Combined With the BX Velocity
Sponsor:
Cordis Corporation
Organization:
Cordis Corporation
Study Overview
Official Title:
Distal Protection Combined With Velocity in Coronary Arteries and SVBG Registry
Status:
COMPLETED
Status Verified Date:
2008-08
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
DISCOVER
Brief Summary:
The primary objective is to evaluate the use of the AngioGuard device combined with the Bx Velocity on patient outcome at one month
Detailed Description:
This is a prospective non-randomized multi-center trial Patients will be treated with the AngioGuard device and Bx Velocity stent and will be followed for six-months post-procedure
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None